Details for 2019790404

Up to date per 16.04.2026

Actions

Title / Product Name

ETRASIMOD ZUR VERWENDUNG IN METHODEN ZUR BEHANDLUNG VON SKLERODERMIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019790404

EP Publication Number

3860590

E-Number

1572817

Language

PCT Number

US19054576

Publication Date

11.08.2021 A

07.06.2023 B1

Registration Date

07.06.2023

AT Publication Date

15.06.2023

Application Date

03.10.2019

Registration Number

Priorities

03.10.2018

201862740855 P

IPC

A61K 31/404 20060101AFI20200410BHEP

Maximum Duration of Protection

03.10.2039

Owner

Arena Pharmaceuticals, Inc.66 Hudson Boulevard East New York, NY 10001-2192US

Representative

No representatives present

Inventor

ADAMS, John W.2515 Geranium Street San Diego, California 92109US